2.180USD+16.58%Mkt Cap: 6.36M USDP/E: —Last update: 2026-06-01
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap6.36M USD
Enterprise Value-950.62K USD
Revenue (TTM)16.57K USD
Gross Profit16.57K USD
Net Income (TTM)-6.50M USD
Revenue/Share0.0080 USD
Last Price2.180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.56
PEG—
EV/EBITDA0.15
EV/Revenue-57.39
P/S337.66
P/B0.63
EPS (TTM)-3.37
EPS (Forward)-0.25
52W Range
0.970017% of range7.910
52W High7.910 USD
52W Low0.9700 USD
Profitability
Gross Margin100.00%
Oper. Margin-66598.40%
EBITDA Margin0.00%
Profit Margin-43832.49%
ROE-93.19%
ROA-83.67%
Growth
Revenue Growth185.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.73M USD
CapEx (TTM)419.31K USD
FCF Margin-23708.10%
FCF Yield-61.72%
Net Debt-6.54M USD
Net Debt/EBITDA1.04
Balance Sheet
Debt/Equity0.10
Current Ratio15.76
Quick Ratio14.41
Book Value/Sh3.008 USD
Cash/Share2.391 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.96M
Float2.83M
Insiders8.31%
Institutions9.34%
Short Interest
Short Ratio0.3d
Short % Float0.64%
Short % Out.0.64%
Shares Short19.00K
Short (prev mo.)53.76K
Technical
SMA 501.870 (+16.6%)
SMA 2002.993 (-27.2%)
Beta2.26
S&P 52W Chg27.94%
Avg Vol (30d)64.66K
Avg Vol (10d)73.27K
Technical Indicators
RSI (14)54.5
MACD-0.0652
MACD Signal-0.1166
MACD Hist.+0.0514
BB Upper2.076 USD
BB Middle1.717 USD
BB Lower1.358 USD
BB Width41.84%
ATR (14)0.1815 USD
Vol Ratio (20d)0.42x